Anti- TB drug abbreviations Am Amx/Clv Cfx Cfz Clr Cm Cs E Eto Gfx H Km
Amikacin Amoxicillin/Clavulanate Ciprofloxacin Clofazimine Clarithromycin Capreomycin Cycloserine Ethambutol Ethionamide Gatifloxacin Isoniazid Kanamycin
Lfx Lzd Mfx Ofx PAS Pto R S Th Trd Vi Z
Levofloxacin Linezolid Moxifloxacin Ofloxacin P-aminosalicylic acid Prothionamide Rifampicin Streptomycin Thioacetazone Terizidone Viomycin Pyrazinamide
References 1. The Stop TB Strategy 2006 – 2015. Geneva, World Health Organization, 2006 (WHO/HTM/TB/2006.368) 2. WHO Report 2007 Global Tuberculosis Control – Surveillance, Planning, Financing. Geneva, World Health Organization, 2007 (WHO/HTM/TB/2007.376) 3. The Global MDR-TB and XDR-TB Response Plan 2007 – 2008. Geneva, World Health Organization, 2007 (WHO/ HTM/TB/2007.387) 4. Tropical Disease Foundation, Inc. (2008). Annual Report to the Green Light Committee. Makati City, Philippines. 5. Quelapio, M. I. D., Egos, G. E., Tupasi, T. E., et. al. XDR-TB in the Philippines. The International Journal of Tuberculosis and Lung Disease, November 2007(11), Supplement 1: S63 6. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs – worldwide 2000 – 2004. Mortality and Morbidity Weekly Report 2006, 55(11), 301 – 305 7. Tupasi, T. E., et al. DOTS – Plus for multidrug-resistant tuberculosis in the Philippines: global assistance urgently needed. Tuberculosis (Edinb) 2003, 83(1-3), 52 – 8. 8. Drug Resistance Surveillance in the Philippines. Manila, Department of Health – National Tuberculosis Program, 2005. 9. Guidelines for the Programmatic Management of Drug-resistant Tuberculosis, World Health Organization, Geneva, Switzerland, 2006. (WHO/HTM/TB/2006.361). 10. Guidelines for the Implementation of the Programmatic Management of Drug-resistant Tuberculosis (PMDT). Administrative Order No. 2008-0018. Department of Health, Manila, Philippines, May 26, 2008.
INTRODUCTION
23
